Elon Musk, now the world’s richest person, had plenty to say during a CodeCon session earlier this week, including psychedelics.
Story continues below
This advertisement has not loaded yet, but your article continues below.
In a wide-ranging discussion covering everything from cryptocurrency and China to President Joe Biden, taxes and stock options, blockchain and billionaire “cashtronauts” exploring space, Musk also fielded an audience question from Ronan Levy, co-founder and executive chairman of Toronto-based Field Trip Health Ltd., which offers a psychedelic-assisted therapy program.
The company recently closed a common share deal worth $95 million, cash that will help finance the development of FT-104, which Levy described to The GrowthOp as an “enhanced, next-generation psychedelic.”
Read full article on The Growth Op
